AdventHealthMD
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
After over a decade of not being able to keep food down because of her condition, Rene Galloway has a new lease on life thanks to an AdventHealth interventional endoscopist who saw a chance to help...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.